2004
DOI: 10.1157/13059044
|View full text |Cite
|
Sign up to set email alerts
|

Utilización de las medicinas alternativas y complementarias por los pacientes con hepatitis C crónica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 0 publications
0
9
1
Order By: Relevance
“…These differences can be related to the variability in the prevalence of anti-HCV antibodies in the general population of these two Mediterranean countries, being much higher in Italy. 22,23 Our study also fails to demonstrate that male gender is a risk factor for HCC in PBC when considering the overall series from Italy and Spain, thus totaling the highest series published. This is opposed to results reported in other studies, 4,5,14-16 a discrepancy that can be explained from the duration of follow-up and the number of patients evaluated.…”
Section: Discussioncontrasting
confidence: 79%
“…These differences can be related to the variability in the prevalence of anti-HCV antibodies in the general population of these two Mediterranean countries, being much higher in Italy. 22,23 Our study also fails to demonstrate that male gender is a risk factor for HCC in PBC when considering the overall series from Italy and Spain, thus totaling the highest series published. This is opposed to results reported in other studies, 4,5,14-16 a discrepancy that can be explained from the duration of follow-up and the number of patients evaluated.…”
Section: Discussioncontrasting
confidence: 79%
“…Similarly, blood safety along with the use of erythropoietin (EPO) and improvement in infection control practices (see below) has greatly decreased HCV infection among haemodialysis patients. Blood safety has also paved the way for IDU to become the main risk factor for HCV transmission (Table 1) and has switched the HCV genotype distribution (among patients younger than 50) (from 1b and 2 to 1a, 3a and 4d) [31,32,76,78,[81][82][83][84][85], and has led vertical transmission to become the almost exclusive source of HCV infection in infants [31,86].…”
Section: Blood Transfusion Safetymentioning
confidence: 99%
“…Subsequently, blood donor screening and use of EPO certainly decreased both prevalence (to <15%) and incidence (to $2.5 per 100 person/years) [91,92]. New infections, however, indirectly transmitted from patient-to-patient via [2,6,[9][10][11][14][15][16]21,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44].…”
Section: Improvement In Safety Of Health-care-related Proceduresmentioning
confidence: 99%
See 1 more Smart Citation
“…These high figures decreased in subsequent years, and our study has documented an estimated average weighted prevalence of HCV infection of 18.6% among alcoholics. Nevertheless, this prevalence is much higher than in the general population, reported to be about 1.5%-2% 1,2 ,although HCV prevalence is expected to decrease dramatically due to the availability of DOI: http://dx.doi.org/10.22192/ijcrms.2017.03.03.002 new treatment 3 , the association of HCV with alcohol consumption still represents a problem of great relevance. In patients with chronic HCV infection, alcohol consumption is a well-known risk factor for progression to advanced forms of liver disease and cirrhosis 4 ; it also increases the risk of developing hepatocellular carcinoma (HCC) 5 .…”
Section: Introductionmentioning
confidence: 97%